FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology. Described is a marker gene for determining cancer cell immortalisation, wherein the marker gene is a polynucleotide having a base sequence of at least 15 successive bases. A method for determining an immortalised cancer cell is disclosed. Described also is a cancer cell immortalisation marker which is a polynucleotide. An antibody to said marker is disclosed. Described is a reagent for determining an immortalised cancer cell, comprising at least one member selected from a group consisting of a marker gene and an antibody. A method for screening a substance for suppressing proliferation of immortalised cancer cells is disclosed. An immortalised cancer cell growth inhibitor containing said polynucleotide as an active ingredient is disclosed.
EFFECT: invention enables to determine an immortalised cancer cell.
16 cl, 28 dwg, 3 tbl, 2 ex
Title |
Year |
Author |
Number |
AVIAN TELOMERASE REVERSE TRANSCRIPTASE |
2007 |
- Ehrb Filipp
- Bajjul' Zhan-Mark
- Kapfer Marina
- Sil'Vestr Natali
|
RU2415867C2 |
THERAPEUTIC COMPOSITIONS AND METHODS AGAINST MALIGNANT TUMORS WITH RNAi MOLECULES DIRECTED AGAINST Hsp47 |
2015 |
- Minomi, Kenjirou
- Tamura, Yasuaki
- Yoneda, Akihiro
- Liu, Jihua
- Majeti, Bharat
- Ying, Wenbin
|
RU2756253C2 |
TOM34 GENE RELATED TO COLON CANCER |
2006 |
- Nakamura Jusuke
- Furukava Joiti
- Takhara Khideaki
- Tsunoda Takuja
- Matsusima Satosi
|
RU2526196C2 |
GENE TOM34 ASSOCIATED WITH CANCER OF LARGE INTESTINE |
2006 |
- Nakamura Jusuke
- Furukava Joiti
- Takhara Khideaki
- Tsunoda Takuja
- Matsusima Satosi
|
RU2449020C2 |
AGENT INDUCING CELL DEATH, CELL GROWTH INHIBITING AGENT, AND PHARMACEUTICAL COMPOSITION FOR TREATING DISEASE CAUSED BY ABNORMAL CELL GROWTH |
2015 |
- Niitsu Yoshiro
- Minomi Kenjirou
- Tanaka Hiroyuki
|
RU2707746C2 |
METHOD FOR INHIBITION OF MALIGNANT TUMOUR METASTASIS OR MALIGNANT CELL MIGRATION BY REDUCING CELL LEVEL OF LYSYL-tRNA-SYNTHETASE (VERSIONS), COMPOSITION AND APPLICATION OF EXPRESSION VECTOR OR KRS ANTIBODY FOR INHIBITION OF MALIGNANT TUMOUR METASTASIS OR MALIGNANT CELL MIGRATION |
2008 |
- Kim Sungkhoon
- Choi Dzin Voo
|
RU2465330C1 |
POLYNUCLEOTIDE MODULATING CANCER CELL PROLIFERATION (VARIANTS), POLYPEPTIDE, MONOCLONAL ANTIBODY, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL AGENT FOR TREATMENT OF PROLIFERATIVE DISEASE, PHARMACEUTICAL COMPOSITION, POLYPEPTIDE USES IN PHARMACEUTICAL AGENT PRODUCTION |
2002 |
- Ferrandi Ehrik
- Kamara I Ferrer Khose-Antonio
- Martine Zhan
- Tjur'O Kristof
|
RU2307666C2 |
POLYPEPTIDE WITH ANTIVIRAL, ANTIPROLIFERATIVE AND/OR IMMUNOMODULATING ACTIVITIES, SEPARATED POLYNUCLEOTIDE |
2002 |
|
RU2328528C2 |
IMMORTALISED CELL LINE OF BIRDS |
2008 |
- Ehrb Filipp
- Kapfer Marina
- Sil'Vestr Natali
|
RU2475536C2 |
IMMUNITY-INDUCING AGENT |
2012 |
- Kurikhara Akira
- Okano Fumiesi
|
RU2634862C2 |